Company Overview
- Headquarters
- 28 Atlantic Ave Ste 129, Boston MA
- Website
- psythx.com
- Phone
- (617) 723-****
- Employees
- 9
- Founded in
- 2012
- Industry
- BioTech/Drugs
- NAICS Code
- 621399, 621, 62, 6213, 62139
- SIC Code
- 80, 804
Financials & Stats
Revenue
$1B
Who is Psy Therapeutics
Psy Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in the United States. With a small team of four employees, Psy Therapeutics focuses on developing innovative treatments for central nervous system disorders. The company specializes in creating novel therapeutics targeting anxiety disorders, depression, and dementia. Psy Therapeutics' pipeline of potential CNS treatments aims to provide new solutions for patients struggling with these challenging conditions. Their research and development efforts are driven by a commitment to improving patient outcomes and addressing unmet medical needs. Psy Therapeutics distinguishes itself through its highly experienced team of neuroscientists, clinicians, and business professionals. Leveraging cutting-edge technologies and strategic collaborations, the company strives to advance its research programs and deliver significant value to patients, supporters, and stakeholders. For further information about Psy Therapeutics, please visit their website at psythx.com.
Psy Therapeutics Tech Stack
Companies Similar to Psy Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Psy Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 11 | 2007 | ||
| 1M | 4 | |||
| 1M | 4 | Washington, WA | 1994 | |
| 1M | 32 | New York, NY | 1983 | |
| 1M | 3 |